A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1997
11/11/1997	US5686586 Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same
11/11/1997	US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997	US5686486 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections
11/11/1997	US5686485 Physiologically active EI-1941 compounds
11/11/1997	US5686480 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
11/11/1997	US5686477 5-(arloxymethyl)oxazolines
11/11/1997	US5686476 Methods of inhibiting Alzheimer's Disease
11/11/1997	US5686473 Treating parkinsons disease, alzheimers disease, dementia and pain
11/11/1997	US5686472 Inhibitors of farnesyl-protein transferase
11/11/1997	US5686468 2-phenyl-3-aroylbenzothiophenes
11/11/1997	US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997	US5686463 Oxadiazoles useful in the treatment of senile dementia
11/11/1997	US5686461 Inhibition of nmda induced convulsions
11/11/1997	US5686460 Antiinflammatory agents, analgesics
11/11/1997	US5686457 Pyrrolopyrimidine derivatives having pharmacological activity
11/11/1997	US5686455 Imidazole derivatives and their use as cytokine inhibitors
11/11/1997	US5686454 Preventing labor, vasodilation, diuresis, hypotensive agents, anticoagulants, treating dysmenorrhea
11/11/1997	US5686434 3-aryl-2-isoxazolines as antiinflammatory agents
11/11/1997	US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
11/11/1997	US5686425 Composition and method for revitalizing scar tissue
11/11/1997	US5686424 For treating inflammation
11/11/1997	US5686415 Method for the treatment of colon epithelial cells in vivo
11/11/1997	US5686414 Methods of treating conditions associated with corneal transplantation
11/11/1997	US5686411 Treatment of diabetes, hypoglycemia
11/11/1997	US5686278 Methods for enhanced retrovirus-mediated gene transfer
11/11/1997	US5686245 Methods for screening for agents which modulate telomere length
11/11/1997	US5686059 Cartilage matrix protein and methods for use
11/11/1997	US5685195 Crank assembly for a screen wiper drive of an automotive vehicle
11/06/1997	WO1997041250A1 Process for producing maturation bone morphogenetic protein
11/06/1997	WO1997041229A1 Antibodies against interferon alpha/beta receptor
11/06/1997	WO1997041211A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them
11/06/1997	WO1997041156A1 Novel compounds
11/06/1997	WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants
11/06/1997	WO1997041129A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
11/06/1997	WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997	WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
11/06/1997	WO1997041121A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997	WO1997041119A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
11/06/1997	WO1997041104A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
11/06/1997	WO1997041103A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	WO1997041099A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997041098A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	WO1997040850A1 Erythropoietin solution preparation
11/06/1997	WO1997040848A1 Use of prolactin as a tgf-beta antagonist
11/06/1997	WO1997040839A1 Dna vaccine formulations
11/06/1997	WO1997040838A1 New use
11/06/1997	WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	WO1997040830A1 Therapeutic treatment for vegf related diseases
11/06/1997	WO1997033608A3 Antagonism of endothelin actions
11/06/1997	WO1997032598A3 Vaccines
11/06/1997	CA2253608A1 Therapeutic treatment for vegf related diseases
11/06/1997	CA2253440A1 New use
11/06/1997	CA2253433A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	CA2253282A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
11/06/1997	CA2253233A1 Process for producing maturation bone morphogenetic protein
11/06/1997	CA2252869A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis
11/06/1997	CA2252455A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them
11/06/1997	CA2232682A1 Use of prolactin as a tgf-beta antagonist
11/05/1997	EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met
11/05/1997	EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997	EP0805153A1 Novel muscarinic receptor agonists
11/05/1997	EP0804933A2 Storage-stable fibrinogen preparations
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804596A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
11/05/1997	EP0804591A1 Serum paraoxonase
11/05/1997	EP0804580A1 Calcium binding recombinant antibody against protein c
11/05/1997	EP0804578A1 Il-2r-associated polypeptide and dna molecules coding therefor
11/05/1997	EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR
11/05/1997	EP0804576A1 A novel haemopoietin receptor
11/05/1997	EP0804572A1 Protein tyrosine kinase agonist antibodies
11/05/1997	EP0804562A1 Connective tissue growth factor-2
11/05/1997	EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997	EP0804479A1 Method of treating diabetes mellitus using kgf
11/05/1997	EP0804476A1 PORE FORMING PEPTIDES FROM $i(GEOLYCOSA RIOGRANDE)
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804464A1 Aromatic heterocyclic derivatives as enzyme inhibitors
11/05/1997	EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997	EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
11/05/1997	EP0804435A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/05/1997	EP0804434A1 Azetidine, pyrrolidine and piperidine derivatives
11/05/1997	EP0804430A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/05/1997	EP0804428A1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/05/1997	EP0804427A1 Lta4 hydrolase inhibitors
11/05/1997	EP0804420A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804415A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same
11/05/1997	EP0804248A2 Chemically modified interferon
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804216A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
11/05/1997	EP0804207A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997	EP0804186A1 Indole diterpene alkaloid compounds
11/05/1997	EP0804184A1 USE OF $g(v)-GUANIDINOCARBOXYLIC ACID ESTERS
11/05/1997	EP0804182A2 Use of gabapentin in the treatment of anxiety and panic
11/05/1997	EP0804180A1 Method of inhibiting cathepsin k

1 ... 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 ... 1564